Editorial Article
Bridging the gap: Transforming multiomic endpoints into actionable human disease discoveries
Guest editorial from Dr. Matt Westfall, Senior Director of Biochemical Pharmacology and Proteomics at Inotiv
Guest editorial from Dr. Matt Westfall, Senior Director of Biochemical Pharmacology and Proteomics at Inotiv
Learn how a US company is changing the paradigm for contract research, combining disease pharmacology, toxicology, and pathology to optimize drug development
STAG will act as an internal funding body for promising research; develop new assays and technologies alongside customers; and attract the next generation of scientists
Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection